Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1017P represents a pseudogene copy of the human U6 small nuclear RNA (snRNA) gene, found within the genome but not transcribed into a functional RNA product. Pseudogenes like RNU6-1017P are formed by the duplication or retrotransposition of functional snRNA genes; they frequently retain sequence similarity to parent genes such as U6 snRNA but typically lack regulatory features for transcription or encode nonfunctional RNA due to mutations or truncations. U6 snRNA itself is a component of the spliceosomal machinery crucial for pre-mRNA splicing, but pseudogenes like RNU6-1017P do not contribute to this process. There is no evidence that RNU6-1017P is biologically functional, therapeutically relevant, or implicated in disease. Pseudogenes are prevalent for U6 snRNA in vertebrate genomes and most are nonfunctional. Sequence analysis of similar U6 snRNA pseudogenes shows they may contain parts of the functional gene but exhibit mutations, rearrangements, or duplications (e.g., direct repeats) that render them inactive. Gene databases (e.g., Ensembl, NCBI, BioGPS) list RNU6-1017P as a pseudogene without functional annotation, protein product, or disease relevance. RNU6-1017P (RNA, U6 small nuclear 1017, pseudogene) is a nonfunctional pseudogene derived from the U6 snRNA gene. It is not a canonical drug or therapeutic target, has no known biological function or disease role, and should not be considered a molecular target for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1017, pseudogene (RNU6-1017P).